TELMICHAK A 10'S

About

TELMICHAK A is a fixed-dose combination medication containing telmisartan, an angiotensin II receptor blocker (ARB), and amlodipine, a dihydropyridine calcium channel blocker (CCB). It is indicated for the treatment of essential hypertension in patients whose blood pressure is not adequately controlled with monotherapy or as initial therapy in patients likely to need multiple drugs to achieve their blood pressure goals. Telmisartan works by blocking the effects of angiotensin II, leading to vasodilation, while amlodipine relaxes and widens blood vessels. This dual mechanism provides complementary actions to effectively lower blood pressure, reduce peripheral vascular resistance, and improve cardiovascular outcomes. The combination offers sustained 24-hour blood pressure control and is particularly beneficial for patients requiring robust antihypertensive therapy.

Uses

• Treatment of essential hypertension.
• For patients not adequately controlled by monotherapy.
• Initial therapy for patients likely to require multiple antihypertensives.
• Reduction of cardiovascular risk in hypertensive individuals.

Directions For Use

Take one tablet orally once daily, with or without food, as directed by your healthcare provider.

Benefits

• Provides powerful and sustained blood pressure reduction.
• Combines two distinct mechanisms for enhanced antihypertensive effect.
• Reduces the risk of stroke, heart attack, and other cardiovascular events.
• Offers convenient once-daily dosing.
• Generally well-tolerated with a good safety profile.
• May improve patient adherence due to combination therapy.

Side Effects

• Dizziness
• Headache
• Peripheral edema (swelling of ankles/feet)
• Fatigue
• Nausea
• Flushing
• Palpitations
• Hypotension
• Abdominal pain
• Somnolence
• Muscle cramps
• Cough (less common than ACE inhibitors)

Safety Measures

• Alcohol - Alcohol may enhance the blood pressure-lowering effect of this medication, potentially leading to dizziness or fainting. Use with caution.
• Pregnancy - Telmisartan is contraindicated during the second and third trimesters of pregnancy due to potential fetal harm. Amlodipine should be used with caution.
• Breastfeeding - Both telmisartan and amlodipine are excreted in breast milk. Breastfeeding is generally not recommended while taking this medication.
• Liver - Use with caution in patients with impaired liver function, as both components are extensively metabolized by the liver. Dosage adjustment may be necessary.
• Kidney - Use with caution in patients with renal artery stenosis or severe renal impairment (due to telmisartan). Amlodipine can be used at usual doses.
• Lung - Generally safe for use in patients with lung conditions, as it does not typically affect respiratory function.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.